用多多巴胺修饰的原蛋白膜充满了富血小板血,以增强糖尿病伤口愈合
Hao-Jie Gao1,2, Xiao-Wan Fang1, Hao Chen1
1Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, People's Republic of China.
Biomedical physics & engineering express
|July 4, 2025
概括
这项研究开发了一种聚多巴胺修饰的原膜,用于持续释放富血小板血 (PRP). 这种新材料通过促进细胞生长和血管形成来加速糖尿病伤口的愈合.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 再生医学是一种再生医学.
背景情况:
- 富含血小板血 (PRP) 促进伤口愈合,但患有不稳定性和快速降解.
- 原蛋白提供生物相容性,而聚多巴胺 (PDA) 可通过表面功能组持续释放.
- 开发稳定的PRP输送系统对于有效的伤口再生至关重要.
研究的目的:
- 制造一种聚多巴胺修饰的原膜 (PDA-CM),用于持续释放PRP (PDA-CM@PRP).
- 评估PDA-CM@PRP在促进人类皮肤纤维细胞 (HDF) 功能中的疗效.
- 评估PDA-CM@PRP在加速糖尿病伤口愈合中的治疗潜力.
主要方法:
- 用PDA修饰的原膜 (PDA-CM) 的制造.
- 将PRP加载到PDA-CM上以创建PDA-CM@PRP.
- 在体外评估HDF的扩散,迁移,衰老和氧化应激.
- 在体内评估糖尿病伤口愈合,包括颗粒组织形成和新血管化.
- 转录组测序以分析参与HDF增殖的分子途径.
主要成果:
- 在实验室中,PDA-CM@PRP显著增强了HDF的增殖,迁移和延迟衰老.
- PDA-CM@PRP在HDF中降低了氧化应激.
- 在体内研究表明,糖尿病伤口愈合加速,细粒组织,细胞增殖和新血管化得到改善.
- 转录组分析表明,PDA-CM@PRP可以提高细胞周期和DNA复制途径的调节.
结论:
- PDA-CM@PRP提供了一种持续提供PRP的新策略,克服了免费PRP的局限性.
- 这种方法在治疗糖尿病伤口和其他慢性伤口类型方面显示出显著的治疗潜力.
- 增强的生物相容性和持续释放特性使PDA-CM@PRP成为一个有前途的再生生物材料.
更多相关视频
07:51Effects of Allogeneic Platelet-Rich Plasma PRP on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
9.3K
10:49Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
Published on: August 21, 2021
4.6K
相关概念视频
01:05Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
01:29Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59